|
KMID : 0043320140370040501
|
|
Archives of Pharmacal Research
2014 Volume.37 No. 4 p.501 ~ p.511
|
|
|
Myriocin induces apoptotic lung cancer cell death via activation of DR4 pathway
|
|
Choi Kyung-Eun
Jung Young-Suk
Kim Dea-Hwan
Song Ju-Kyung
Kim Ji-Young
Jung Yu-Yeon
Eum So-Young
Kim Joo-Hwan
Yoon Na-Young
Yoo Hwan-Soo
Han Sang-Bae
Hong Jin-Tae
|
|
|
Abstract
|
|
|
|
It has been known that myriocin inhibits melanoma growth. However, the effects and action mechanisms of myriocin on lung cancer cell growth have not been reported. In this study, we examined whether myriocin isolated from Mycelia sterilia inhibits cell growth of lung cancer cells (A549 and NCI-H460) as well as possible signaling pathways involved in cell growth inhibition. Different concentrations of myriocin inhibited the growth of lung cancer cells through the induction of apoptotic cell death. Consistent with cancer cell growth inhibition, myriocin induced the expression of death receptors (DRs) as well as p-JNK and p-p38 in both cell lines. Moreover, the combination of myriocin with DR4 ligand TRAIL, and other well known anti-tumor drugs (docetaxel and cisplatin) synergistically inhibited cancer cell growth, and induced DR4 expression. These results showed that myriocin inhibits lung cancer cells growth through apoptosis via the activation of DR4 pathways, and enhanced anti-cancer effects with well known drugs. Thus, our study indicates that myriocin could be effective for lung cancer cells as an anti-cancer drug and/or a conjunction agent with well known anti-cancers.
|
|
|
KEYWORD
|
|
|
Myriocin, Apoptosis, Death receptors, MAP kinase, Lung cancer
|
|
|
FullTexts / Linksout information
|
|
|
|
|
|
Listed journal information
|
|
  
|